CNS Pharmaceuticals Inc (CNSP) Stock Price, Quote, News & History

CNSPNASDAQ
$5.90
-0.04-0.67%
Last update: Aug 25, 11:22 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-13.41M
Investing Cash Flow (TTM)
-28.18K
Financing Cash Flow (TTM)
21.30M
Free Cash Flow (TTM)
-13.44M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
7.86M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$5.96M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.48
Earnings Yield % (TTM)
-259.09%
Earnings Yield % (FWD)
-161.62%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$12.45

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$19.99M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-$308.55K

Key Statistics

Open
$5.74
Close
-
Volume / Avg.
7.44K / 28.53K
Day Range
$5.74 - $6.05
52 Wk Range
1.90 - 10.59
Market Cap
$8.62M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
0.78%
Days to Cover
1.22

About

Sector
Health Care
Industry
Pharmaceuticals
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoti...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy CNS Pharmaceuticals (CNSP) stock?

A

You can purchase shares of CNS Pharmaceuticals (NASDAQ:CNSP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CNS Pharmaceuticals (CNSP) competitors?

Q

What is the forecast, or price target, for CNS Pharmaceuticals (CNSP) stock?

A

CNS Pharmaceuticals has a consensus price target of $20.00.

Q

What is the current price for CNS Pharmaceuticals (CNSP)?

A

The stock price for CNS Pharmaceuticals (NASDAQ: CNSP) is $5.9 last updated August 25, 2026 at 11:22 AM EDT.

Q

Does CNS Pharmaceuticals (CNSP) pay a dividend?

A

There are no upcoming dividends for CNS Pharmaceuticals.

Q

When is CNS Pharmaceuticals (NASDAQ:CNSP) reporting earnings?

A

CNS Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is CNS Pharmaceuticals (CNSP) going to split?

A

There is no upcoming split for CNS Pharmaceuticals.

Q

What sector and industry does CNS Pharmaceuticals (CNSP) operate in?

A

CNS Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.